ACC 2022

EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries

C. Michael Gibson, Tijn Jansen, and Suzette Elias-Smale discuss the EDIT-CMD trial presented at ACC 2022.

We Recommend